JP2004275169A5 - - Google Patents

Download PDF

Info

Publication number
JP2004275169A5
JP2004275169A5 JP2003117617A JP2003117617A JP2004275169A5 JP 2004275169 A5 JP2004275169 A5 JP 2004275169A5 JP 2003117617 A JP2003117617 A JP 2003117617A JP 2003117617 A JP2003117617 A JP 2003117617A JP 2004275169 A5 JP2004275169 A5 JP 2004275169A5
Authority
JP
Japan
Prior art keywords
sirna
dinucleotide
rna
partial
midkine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003117617A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004275169A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2003117617A priority Critical patent/JP2004275169A/ja
Priority claimed from JP2003117617A external-priority patent/JP2004275169A/ja
Publication of JP2004275169A publication Critical patent/JP2004275169A/ja
Publication of JP2004275169A5 publication Critical patent/JP2004275169A5/ja
Pending legal-status Critical Current

Links

JP2003117617A 2003-03-17 2003-03-17 ｓｉＲＮＡを用いたヒトミッドカインの発現の強い抑制。 Pending JP2004275169A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2003117617A JP2004275169A (ja) 2003-03-17 2003-03-17 ｓｉＲＮＡを用いたヒトミッドカインの発現の強い抑制。

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003117617A JP2004275169A (ja) 2003-03-17 2003-03-17 ｓｉＲＮＡを用いたヒトミッドカインの発現の強い抑制。

Publications (2)

Publication Number Publication Date
JP2004275169A JP2004275169A (ja) 2004-10-07
JP2004275169A5 true JP2004275169A5 (enExample) 2005-08-11

Family

ID=33296313

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003117617A Pending JP2004275169A (ja) 2003-03-17 2003-03-17 ｓｉＲＮＡを用いたヒトミッドカインの発現の強い抑制。

Country Status (1)

Country Link
JP (1) JP2004275169A (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1314698C (zh) * 2004-11-05 2007-05-09 浙江大学 针对中期因子基因的小干扰核糖核酸分子及其用途
ES2405357T3 (es) * 2005-05-25 2013-05-30 Cellmid Limited Composición farmacéutica para la vasculopatía oclusiva.
EP1964574B1 (en) 2005-11-14 2016-09-07 Cellmid Limited Method for treatment or prevention of disease associated with functional disorder of regulatory t cell

Similar Documents

Publication Publication Date Title
RU2010119292A (ru) Способный к интерференции дуплекс рнк, имеющий "тупые" концы и 3'-модификации
WO2006083800A3 (en) Nucleic acid silencing of huntington's disease gene
JP2009528027A5 (enExample)
FR2866884B1 (fr) Derives d'aryl-et d'heteroaryl-piperidinecarboxylates, leur preparation et leur application en therapeutique
JP2004525194A5 (enExample)
FR2864080B1 (fr) Derives de 1-piperazine-et-1-homopiperazine-carboxylates, leur preparation et leur application en therapeutique
WO2008030996A8 (en) Sirna and methods of manufacture
IS2733B (is) Afleiður af díoxan-2-alkýlkarbamötum, framleiðsluaðferð þeirra, milliefni notuð við framleiðsluna, og notkun þeirra í meðferð.
DK1603915T3 (da) Substituerede 8-pyridinyl-dihydrospiro-cycloalkyl-pyrimido- 1,2-a-pyrimidin-6-on og 8-pyrimidinyl-dihydrospiro-cycloalkyl-pyrimido-1,2-a-pyrimidin-6-on-derivater og deres anvendelse mod neurogenerative sygdomme
FR2850377B1 (fr) Derives d'arylalkylcarbamates, leur preparation et leur application en therapeutique
MA28343A1 (fr) Derives de type aryloxyalkylcarbamates, leur preparation et leur application en therapeutique
FR2866340B1 (fr) Derives d'oxazole, leur preparation et leur utilisation en therapeutique.
IL153388A0 (en) Manipulation of negative stranded rna viruses by rearrangement of their genes and uses thereof
JP2003079658A5 (enExample)
IS8575A (is) 3-ß-D-ríbófúranósýlþíasóló [4,5-d]pýridímínnúkleósíð og notkun þeirra
FR2873690B1 (fr) Derives d'oxopiperidine, leur preparation et leur application en therapeutique
JP2004275169A5 (enExample)
JP2006505391A5 (enExample)
WO2005000320A3 (en) Use of double-stranded ribonucleic acid for inducing cell lysis
EP1591525A3 (de) Oligoribonukleotide zur Behandlung von irritativen und/oder entzündlichen Hauterscheinungen durch RNA-Interferenz
JP2004520815A5 (enExample)
FR2860792B1 (fr) Derives de thiophene-2-carboxamide, leur preparation et leur application en therapeutique
NO20034237L (no) Ny fremgangsmate for den industrielle syntese av metyldiesteren av 5-amino-3-karboksymetyl-4-cyano-2-tiofenkarboksylsyre, og anvendelse i syntesen av bivalente salter av ranelinsyre og deres hydrater
FR2873693B1 (fr) Derives d'amino-tropane, leur preparation et leur application en therapeutique
DE502004002124D1 (de) Sio2-formkörper, verfahren zu ihrer herstellung und verwendung